HAWAII DOC TALKS 2025 SCHEDULE
DAY 1
Thursday, February 6, 2025
9:30am – 11:30am
Pre-conference Workshop: Integrative Systematic Approaches to Mold and Mycotoxin Care
Kristi Morlan-Hughes, ND, IFMCP, FMHCH
Integrative Systematic Approaches to Mold and Mycotoxin Care
Mold exposure and mycotoxin toxicity pose significant challenges to health, often
overlooked or misdiagnosed in clinical settings. The post-viral era has increased the prevalence and
discovery of mold-related health concerns. This workshop aims to equip healthcare practitioners with
comprehensive, integrative approaches to identify, treat, and support patients affected by mold
exposure and the clinical sequalae that include the nuances of mold-related illnesses, Chronic
Inflammatory Response System (CIRS), and Mast Cell Activation Syndrome (MCAS).
Mold-related illnesses are increasingly recognized as significant contributors to chronic health issues,
inflammation, hyper-responsive allergenicity, and autonomic dysregulation. Identifying mold exposure
and effectively managing its impact on health require a multifaceted approach integrating various
disciplines of medicine.
12:00 – 12:30
Welcome and Opening Blessing- Michael Traub, ND and Corinne Maul De Soto, ND
12:30 – 1:00
Alena Guggenhein, ND and Kate Smith, ND
Exploring New Pain Paradigms Part 1
Addressing chronic pain presents many challenges and we are all too familiar with situations where our tools to address pain just don’t work. Perhaps this is driven in part because we are working in an outdated model of pain: neuropathic versus nociceptive versus inflammatory. This series of talks seeks to educate integrative providers about the new neuroscience of pain. A new perspective will be explored through a dynamic interchange between two pain centered providers who approach neuroplastic pain from different vantage points. The mutual goal is to create biological and nervous system safety in patients that feel the opposite in their bodies.
1:00 – 1:30
Sarah Strong, ND
Primary Care's Role in Type 1 Diabetes RX
Dr Strong will present on the roll that primary care physicians can play in screening, diagnosing, and managing type 1 diabetics and would like to review recent research in the search for a cure.
1:30 – 2:00
Corinne De Soto, ND
Rare Tropical Diseases Grand Rounds: Diseases you’ve maybe never heard of but should know if you live, work or travel to Hawaii
2:00 – 2:30
Panel Q&A with Drs. Guggenheim, Smith, Strong, and De Soto
2:30 – 3:15
Exhibit Break, sponsored by Laura James
3:15 – 3:45
DeJarra Sims, ND
Transformative Healing for Chronic Skin Conditions: A Naturopathic Approach
Join Dr. DeJarra K. Sims, ND, as she reveals her comprehensive framework for effectively treating chronic skin conditions. Tailored for primary care naturopathic doctors, this high-energy session will provide a strategic approach to integrating naturopathic therapies with a focus on chronic skin issues. Attendees will delve into the gut-brain-skin connection, understanding how these interrelationships impact skin health. Dr. Sims will share innovative protocols that align with your existing knowledge, offering actionable strategies and case studies to enhance patient outcomes. You’ll walk away with a clear, actionable framework for transforming the skin health of your patients and setting your practice apart, ready to implement these strategies immediately.
3:45 – 4:15
Megan Taylor, ND
Approaches to Visceral Hypersensitivity in the Complex GI Patient
Visceral hypersensitivity (VH) is not a new concept, but an essential one for understanding the mechanisms behind Functional Abdominal Pain Disorders, such as Irritable Bowel Syndrome and Functional Dyspepsia. It has been easy to overlook this complicated and complicating condition in our professions’ focus on underlying dysbiosis conditions (ie, SIBO, IFO) and motility disorders, but understanding how to recognize and treat VH is essential to treating the complicated GI patient. This presentation will quickly review some of the key new research insights into the pathomechanisms behind the development of VH, empower clinicians to recognize it clinically, and develop an evidence-based., multi-pronged approach for treatment which can unlock
4:15 – 4:45
Donald I. Abrams, MD
The Integration of An Oncologist or Re-Inventing Your Career to Avoid Burnout
Being in the right place at the right time can greatly influence career pathways. An Oncology Fellow working in Harold Varmus’ retrovirology lab, I tried to convince basic science colleagues to investigate in the disease that befell us in 1981. Unsuccessful there, so I became an AIDS Oncologist. With no effective treatment, I investigated many “alternative” therapies becoming the champion of complementary therapies in HIV. In 1992 I was challenged to study cannabis as a treatment for the AIDS wasting syndrome. Thus began a 5-year struggle with the government that eventually was rewarded with a million dollars and 1400 government “joints” to study. Cannabis research gave me a strong appreciation of the power of plants as medicine which took me to the Telluride Mushroom Festival where I learned from Andrew Weil of the fellowship in Integrative Medicine that I subsequently pursued and became an integrative oncologist. Stories will be shared!
4:45 – 5:15
Q&A with Drs Sims, Taylor, and Abrams
5:30
Join us for our Ohana Picnic Dinner!
DAY 2
Friday, February 7, 2025
8:00am
Breakfast
8:30 – 9:00
Ryan Bradley, ND, MPH
Getting to the Heart of Cannabis 2025 Update RX
Cannabis sativa is a potent herbal medicine, with numerous potentially beneficial applications in clinical care. Yet, with increasing medical and recreational access to Cannabis, some concerns are increasing related to its cardiovascular health effects. Increasing epidemiologic evidence suggests Cannabis use is associated with arrhythmia, myocardial infarction, and premature cardiovascular mortality. Yes, recent evidence suggests some of the risk may be overstated. This presentation will summarize the state of new science from 2023 to the end of 2024 related to the cardiovascular health effects of Cannabis, including potential mechanisms directly related to cannabinoid receptor function, and route type of administration.
9:00 – 9:30
Alena Guggenhein, ND and Kate Smith, ND
Exploring New Pain Paradigms Part 2
Addressing chronic pain presents many challenges and we are all too familiar with situations where our tools to address pain just don’t work. Perhaps this is driven in part because we are working in an outdated model of pain: neuropathic versus nociceptive versus inflammatory. This series of talks seeks to educate integrative providers about the new neuroscience of pain. A new perspective will be explored through a dynamic interchange between two pain centered providers who approach neuroplastic pain from different vantage points. The mutual goal is to create biological and nervous system safety in patients that feel the opposite in their bodies.
9:30 – 10:00
Koichi Tanji, ND, LMHC, FMAPS
The Neurological Consequences of Screen Addiction: Unveiling a Hidden Impact on Pediatric Development
The presentation “The Neurological Consequences of Screen Addiction: Unveiling a Hidden Impact on Pediatric Development” explores the intricate relationship between excessive screen time and its impact on the neurological development of children. It sheds light on the often-overlooked consequences of screen addiction, delving into the ways in which prolonged exposure to screens can affect the developing brains of young individuals. Through a comprehensive analysis of scientific research and case studies, the presentation elucidates the neurological mechanisms underlying screen addiction and its detrimental effects on pediatric development. It highlights how excessive screen time can disrupt neural pathways, impair cognitive functions, and hinder emotional regulation in children. Moreover, the presentation addresses the hidden nature of these neurological consequences, emphasizing the importance of raising awareness and implementing preventive measures. It underscores the need for a multidisciplinary approach involving parents, educators, healthcare professionals, and policymakers to mitigate the impact of screen addiction on pediatric neurological development. By uncovering the hidden neurological consequences of screen addiction, this presentation aims to empower stakeholders with knowledge and strategies to promote healthy screen habits and optimize the neurological well-being of children.
10:00 – 10:30am
Q&A Panel with Drs Bradley, Guggenheim, Smith, and Tanji
10:30 – 11:15am
Exhibit Break
11:15am – 11:45am
DeJarra K. Sims, ND
Boost DEI Impact in Healthcare: Hands-On Strategies for Real Results
Want to supercharge your DEI initiatives in healthcare? Join Dr. DeJarra K. Sims, ND, for a high-energy, hands-on session where you’ll learn game-changing strategies to foster empathy, improve communication, and build inclusive teams. Through dynamic, interactive exercises, you’ll break down barriers and create a culture of collaboration. This isn’t your typical training—get ready for an experience that will transform how you approach DEI in your practice.
11:45 – 12:15
Michael Traub, ND, FABNO
Good Drugs and Bad Drugs: a critical appraisal of common pharmaceuticals from a 40-year perspective
As a pathfinding naturopathic physician deeply involved in the development of
integrative medicine, Dr. Traub’s practice has evolved over 40 years from specializing in
classical homeopathy, midwifery, HIV and AIDs, to integrative dermatology and
oncology. This experience has given him a unique perspective on the role of
pharmacology in the naturopathic profession.
He served as a member of the Naturopathic Formulary Advisory Committee for the
California Bureau of Naturopathic Medicine and was the primary author of the
Naturopathic Formulary for the Hawaii Board of Naturopathic Medicine. He uses
pharmaceutical drugs carefully and strategically and is acutely aware of their benefits
and risks. This presentation is a summary of when and how to safely prescribe drugs
and avoid the pitfalls inherent in their utilization. In Dr. Traub’s experience, naturopathic
physicians prescribe pharmaceuticals more judiciously than allopathic providers and
certainly have more expertise in avoiding drug-related adverse effects and drug-
supplement interactions.
12:15 – 12:45
Sarah Strong, ND
PART 1: Type 1 Diabetes in Primary Care: Management, Research, and Naturopathic Adjuncts
Dr Strong will present on the roll that primary care physicians can play in screening, diagnosing, and managing type 1 diabetics and will review recent research in the search for a cure.
12:45 – 1:15pm
Q&A Panel with Drs Sims, Strong, and Traub
2:30 – 4:30
Optional Workshop: Lindsay Adrian, ND
Workshop: Identifying the constellation of symptoms that help identify patients with complex chronic illnesses
Complex Chronic Disease – what is included in this diagnostic umbrella and how do we identify these patients so they can be treated appropriately. These are the patients who inevitably have multiple layers of dysfunction and multiple causative factors. They have often been ill for a long time and are often only marginally improved by treatments you expect to help. What are the hallmark symptoms of the major contributors to illness, and how can these present in patients. Various infections, toxins, and other contributors to disease can create multilayer symptom pictures – what patterns can we see. A constellation approach to diagnosis – the details are important, but not as important as how they are interrelated in the big picture. How do we conceptualize this, a shift in diagnostic perspective is essential for these patients. Creating treatment strategies by identifying intersecting pathophysiology and repairing damaged systems – treating the cause is important, but not more so than repairing the broken systems that allowed the illness to occur in the first place. We will discuss some strategies for creating treatment plans to support these patients; there is no algorithm, but we can hold a big picture for treatment and refine for each individual patient.
DAY 3
Saturday, February 8, 2025
8:00am
Breakfast – sponsored by Thaena
8:30 – 9:00
Andrea McBeth, ND
Postbiotics & the Future of GI Health: A Look at ThaenaBiotic®
Discover the Next Frontier in Gut Health: Join us for a breakfast seminar with Andrea McBeth, ND, as she explores the science behind Thaenabiotic and the transformative potential of postbiotics in gastrointestinal wellness.
9:00 – 9:30
Donald I. Abrams, MD
Oncologists’ Concerns Regarding Cannabis Use in Cancer Patients RX
Oncologists are generally supportive of cannabis for ameliorating cancer and treatment- related symptoms despite having some concerns. A major issue is the belief held by some patients that cannabis can cure cancer. Although pre-clinical evidence is promising, human data is lacking. Fears that patients may develop cancer from use of cannabis, especially when inhaled, can be largely allayed. The feared risk of pulmonary aspergillosis is virtually non-existent. A valid concern is the possibility of cannabinoid:cancer therapy pharmacokinetic interactions mediated via cytochrome p450 isoforms, of greatest concern in patients electing to consume highly concentrated tinctures or oils of delta-9-tetrahydrocannabinol and/or cannabidiol. Observational studies suggest that patients using cannabis while receiving check point inhibitor immunotherapy have significantly shorter survival than patients who do not. Patients and oncologists note improvement in pain, insomnia, anxiety, appetite and nausea despite the paucity of data generated from randomized clinical trials due to existing barriers to research.
9:30 – 10:00
Brenden Cochran, ND
Power Up: Unlocking the Potential of Mitochondrial-Focused IV Therapies
This course will cover the how to approach mitochondrial focused diseases using intravenous agents. We will review the pharmacology, mechanisms of action and how to administer. You will understand safe delivery of each nutrient and an example protocol of combining these IV deliverables
10:00 – 10:30
Koichi Tanji, ND, LMHC, FMAPS
The Neurological Consequences of Screen Addiction: Unveiling a Hidden Impact on Pediatric Development - Part 1
The presentation “The Neurological Consequences of Screen Addiction: Unveiling a Hidden Impact on Pediatric Development” explores the intricate relationship between excessive screen time and its impact on the neurological development of children. It sheds light on the often-overlooked consequences of screen addiction, delving into the ways in which prolonged exposure to screens can affect the developing brains of young individuals. Through a comprehensive analysis of scientific research and case studies, the presentation elucidates the neurological mechanisms underlying screen addiction and its detrimental effects on pediatric development. It highlights how excessive screen time can disrupt neural pathways, impair cognitive functions, and hinder emotional regulation in children. Moreover, the presentation addresses the hidden nature of these neurological consequences, emphasizing the importance of raising awareness and implementing preventive measures. It underscores the need for a multidisciplinary approach involving parents, educators, healthcare professionals, and policymakers to mitigate the impact of screen addiction on pediatric neurological development. By uncovering the hidden neurological consequences of screen addiction, this presentation aims to empower stakeholders with knowledge and strategies to promote healthy screen habits and optimize the neurological well-being of children.
10:30 – 11:00
Q&A Panel with Drs McBeth, Abrams, Cochran, and Tanji
11:00 – 11:45
Exhibit Break
11:45 – 12:15
Lisa A. Price, ND, CBMRA
Part 1: Psilocybin: History of Use, ethics, indigenous use, western use; Naturopathic role in 'plant' medicines
Psilocybin-containing mushrooms have long been consumed in spiritual and divinatory ceremonies long before their use was recorded by the Spanish in the 16th Century despite efforts to destroy evidence of their use. South American Aztec Indians referred to them as teonanacatl, meaning ‘god’s flesh, and they used them in religious and healing rituals. In 1958, Albert Hofman isolated psilocybin from these mushrooms and it ushered in western use and investigation. With Western discovery and more recently the renaissance of their use, questions around access and ethical use have emerged. This talk will review the indigenous history of use, western discovery, differences in medicinal application, access and ethics of use.
12:15 – 12:45
Sally Boyd Daughtrey, ND
A Fresh Look at Autoimmune Disease: What if the body is not making a mistake?
What is behind the autoimmune epidemic? Conventional medical thought posits that autoimmune disease is a complex and mysterious mistake of the immune system. Logically then, conventional treatment of autoimmune disease is suppressive to the misbehaving immune system. This strategy can produce short-term impressive symptom amelioration, but in this view of autoimmune disease the condition is ultimately progressive and incurable. However, a minor but significant body of research points to a different, more hopeful view of Autoimmune disease. This talk will explore the intracellular chronic infection and molecular mimicry theories of autoimmune disease. I will present our in-house case study results, involving 7 years of applying a Naturopathic interpretation of the healing strategies of the Autoimmunity Research Foundation, the Arthritis Trust of America and the Marshall Protocol. Case studies include those with Sarcopenia, Hashimoto’s, Rheumatoid Arthritis, Asthma and SLE. This talk will explore a viable alternative and novel treatment concept for autoimmune diseases, one that allows hope for cure rather than progression.
12:45 – 1:15
Sharon Gurm, ND
Exploring the clinical application of innovative treatments in integrative oncology photodynamic therapy and local-regional hyperthermia
This lecture will have a focus on anorectal and prostate cancers, with a discussion on the standard-of-care approach and the challenges experienced by patients and clinicians with SOC alone and proposed integrative management/treatment solutions. The application of novel treatment strategies will be discussed, including PDT and local-regional hyperthermia, in tandem with other complementary therapies to improve the rate of complete response, avoid the need for surgery and prevent recurrence. Dr. Gurm will present the clinical data supporting complementary therapies, along with several case studies to demonstrate the effectiveness of a novel integrative approach.
1:15 – 1:45
Q&A Panel with Drs Price, Boyd Daughtrey, and Gurm
2:30 – 4:30
Michael Ancharski, N.D.
Workshop: Clinical Pearls in Obstetrics and Pediatrics
Dr. Michael Ancharski (N.D.) gives practical advice on commonly encountered obstetric and pediatric conditions including Diagnostic and Therapeutic Approaches.
6:30 – 9:30pm
HSNP Annual Meeting & Dinner
DAY 4
Sunday, February 9, 2025
8:00am
Breakfast
8:30 – 9:00
Brenden Cochran, ND
Glutathione Fortify Your Inner Shield
There are several different applications for glutathione. Which is the best current delivery method and ways we can support bodies production of glutathione.
9:00 – 9:30
Megan Taylor, ND
Microbiome Restoration: Our current toolkit and its limitations
“Microbiome Restoration” feels like THE current pop wellness topic on the internet, with patients clamoring for the “right” approaches and no shortage of available products marketed for the purpose. The necessity for tools to restore gut-based microbial communities is obvious; nearly all major disease processes, from autoimmunity to cardiometabolic disease to neurological disorders such as Parkinson’s and Alzheimer’s have been associated with various forms of dysbiosis. And persistent and recurrent dysbiosis can keep many of our GI patients stuck on what feels like a never-ending merry-go-round of treatments. Understanding how to rebalance the health of our gut microbial ecosystem is essential! But just how much do we actually know about HOW to do this? What role do pre-, pro-, and post-biotics play in attempts at microbiome restoration and how effective are they, really? This presentation will explore the currently available research on commonly utilized microbiome restoration techniques in clinical practice, discuss tips for developing patient-oriented and evidence-informed treatment protocols, and highlight key gaps in our current knowledge around how to achieve the very important and very lofty goal of “Microbiome Restoration”.
9:30 – 10:00
Sally Boyd Daughtrey, ND
Researching Extreme Diets: Health Tools Or Health Disasters?
We will take a dive into what is currently known and unknown about the benefits and risks of several extremely restrictive food plans that are trending today. Discussion will include brief summaries of the current research and observations from my medical practice on veganism, the ketogenic diet, and the ‘carnivore’ diet. If time allows, insight into the psychological drivers of extreme dieting behavior will also be discussed. Included will be a summary of the progress of ‘The Carnivore Diet Nutritional Assay Project’, an in-house clinical research project currently underway at Mountain Apple Medicine and Apple A Day Primary Care. Our clinics are conducting a study on the functional nutritional adequacy of the carnivore diet as compared to a Mediterranean omnivorous diet. We are enrolling participants following a ‘carnivore’ diet for at least 3 months with age and gender matched Mediterranean diet controls. The study involves a pre and post diet health assessment questionnaire, physical exam, and basic lab work and a post diet RBC Cellular Micronutrient Assay on 5-10 carnivore diet patients and controls.
10:00 – 10:30
Q&A Panel with Drs Cochran, Taylor, and Boyd Daughtrey
10:30 – 11:15
Exhibit Break
11:15 – 11:45am
Lisa A. Price, ND, CBMRA
Part 2: Psilocybin the Science: Mechanism of action, safety; current research indication; research gaps; legislative update
Since the western discovery of psilocybin-containing mushrooms, scientists have attempted to understand their mechanism of action and safety. In addition, they have used this information to discover appropriate indications. In this talk we’ll review the safety, and the fascinating mechanism of action of psilocybin. We’ll also review current research and indications, as well as research gaps and reasons for these gaps.
11:45 – 12:15pm
Ryan Bradley, ND, MPH
Plastic, plastic everywhere, not a drop to drink
Microplastic has been detected in everything from testicular tissue, coronary atheromas, and neonatal blood samples, to coastal sea breezes. But what are the known health implications of ubiquitous exposure to microplastics? This presentation will review recent observation and experimental evidence regarding the human health risks of microplastic exposure, with an emphasis on reproductive and cardiometabolic risks. The presentation will conclude with strategies to reduce or eliminate plastic exposure, including common household sources as well as filtration or binding strategies.
12:15 – 12:45pm
Sharon Gurm, ND
Exploring the clinical application of innovative treatments in integrative oncology photodynamic therapy and local-regional hyperthermia
This lecture will have a focus on anorectal and prostate cancers, with a discussion on the standard-of-care approach and the challenges experienced by patients and clinicians with SOC alone and proposed integrative management/treatment solutions. The application of novel treatment strategies will be discussed, including PDT and local-regional hyperthermia, in tandem with other complementary therapies to improve the rate of complete response, avoid the need for surgery and prevent recurrence. Dr. Gurm will present the clinical data supporting complementary therapies, along with several case studies to demonstrate the effectiveness of a novel integrative approach.
12:45 – 1:15pm
Q&A Panel with Drs Price, Bradley, & Gurm
2:00 – 4:00pm
Stefani Kovacovsky Hayes, ND, LAc and Lara Williams, MD, MHSc, FACOG, IFMCP, FAARM, ABOIM, NCMP
Workshop: Your Guide to Managing Endometriosis Through All Stages of Life RX
Do a deep dive with integrative care specialists, Dr. Williams and Dr. Hayes, on proactive and collaborative endometriosis management. This chronic condition is like a chimera with multiple ways it can hide behind the guise of other conditions, including SIBO/IBS, pelvic floor dysfunction, interstitial cystitis, and unexplained infertility. Not only do these conditions mask endometriosis and complicate the internal landscape of this condition, but they also need to be managed in their own right. Lost in years of confusion and struggle, patients often wait 8 years, on average, before receiving a formal diagnosis. Unfortunately for many, even once diagnosed, they can continue to struggle. Find out how to collaboratively manage these patients for their wellness throughout their entire menstruating years. Learn when to recommend surgery if needed and how to avoid it when possible. Understand the benefits of combining western and natural medicines together to manage endometriosis and all its concomitant conditions. Learn numerous treatment techniques and tips for diagnosis, symptom management and long-term disease stability, to improve patients’ fertility, minimize pain, optimize GI wellness, and maintain pelvic anatomy. Numerous clinical pearls will be shared through chronic case management examples.
Don't Be Shy. Get In Touch.
If you are interested in joining us in Hawaii in any way, reach out to us!